Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Cognitive rehabilitation to help veterans with psychogenic nonepileptic seizures (PNES)

Official title: Cognitive and Functional Telehealth-based Assessment and Intervention in Veterans With Psychogenic Nonepileptic Seizures

Run by VA Office of Research and Development · NCT07316543 · Data updated 2026-11-12

This program will try a telehealth cognitive rehabilitation workbook and sessions (CRAFT) to help U.S. veterans with PNES improve thinking skills and everyday functioning.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment47 (estimated)
SponsorVA Office of Research and Development
Federal
Locations1 site (Providence, Rhode Island)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedJuly 1, 2031
Study endsJuly 1, 2031
Registry record updatedMarch 12, 2026
Trial IDNCT07316543 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are U.S. veterans with a prior video-EEG diagnosis of PNES who report cognitive difficulties, can provide consent, read at least an eighth-grade level, speak English, and have a private space with a computer and internet for telehealth sessions.

Probably not a fit

Patients with dementia or intellectual disability, acute psychosis, active suicidality, significant sensory impairments that prevent participation, or those without the required computer/internet access are unlikely to benefit or to be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Psychogenic nonepileptic seizures (PNES) are a common and disabling form of functional neurological disorder in veterans, and cognitive problems are frequent and limit daily life. The project will begin with qualitative interviews of veterans with PNES to gather direct input for a cognitive rehabilitation workbook adapted from successful approaches used in related conditions. The workbook and treatment protocol will be iteratively refined with feedback from veteran participants and their clinicians and will be delivered via telehealth. The finalized cognitive intervention will be pilot tested to collect feasibility, acceptability, and preliminary outcome data to inform a fully powered randomized trial.

Why it matters

Potential benefit: If successful, the intervention could improve cognition and everyday functioning for veterans with PNES and produce a telehealth-ready rehabilitation program adaptable to other functional neurological disorders.

How similar studies have gone: Cognitive rehabilitation has produced functional gains in related conditions such as traumatic brain injury, but this is the first intervention specifically developed and pilot-tested to target cognition in PNES.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* U.S. Veteran
* able to provide informed consent
* reports cognitive difficulties
* prior video EEG diagnosis of PNES
* English speaking
* able to read at least at 8th grade level
* access to a private space with a computer (13-inch monitor)
* internet access

Exclusion Criteria:

* acute psychosis (hallucinations or delusions)
* current active suicidality
* a diagnosis of dementia or intellectual disability
* sensory impairment (e.g., deafness) that would preclude participation

Where it's running

  • Providence VA Medical Center, Providence, RI
    Providence, Rhode Island, United States
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.